<SEC-DOCUMENT>0001140361-21-035202.txt : 20211022
<SEC-HEADER>0001140361-21-035202.hdr.sgml : 20211022
<ACCEPTANCE-DATETIME>20211022161259
ACCESSION NUMBER:		0001140361-21-035202
CONFORMED SUBMISSION TYPE:	8-A12B
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20211022
DATE AS OF CHANGE:		20211022

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brooklyn ImmunoTherapeutics, Inc.
		CENTRAL INDEX KEY:			0000748592
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				311103425
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-A12B
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11460
		FILM NUMBER:		211340671

	BUSINESS ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220
		BUSINESS PHONE:		(212) 582-1199

	MAIL ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN BUZZTIME INC
		DATE OF NAME CHANGE:	20051230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN COMMUNICATIONS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALROY INDUSTRIES INC
		DATE OF NAME CHANGE:	19850411
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-A12B
<SEQUENCE>1
<FILENAME>brhc10030005_8a12b.htm
<DESCRIPTION>8-A12B
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 8.0.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">


  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="text-align: center; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
      <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM 8-A</div>
      <div style="text-align: center; font-weight: bold;"><font style="font-size: 18pt;"> </font><br>
      </div>
      <div style="text-align: center; font-weight: bold;">FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES</div>
      <div style="text-align: center; font-weight: bold;">PURSUANT TO SECTION 12(b) OR (g) OF</div>
      <div style="text-align: center; font-weight: bold;">THE SECURITIES EXCHANGE ACT OF 1934</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-size: 24pt; font-weight: bold;">Brooklyn ImmunoTherapeutics, Inc.</div>
      <div style="text-align: center; font-weight: bold;">(Exact name of registrant as specified in its charter)</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z6b56e5435776477e814949a04bdcc2f0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Delaware</div>
            </td>
            <td style="width: 2%; vertical-align: bottom;">&#160;</td>
            <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">31-1103425</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(State or incorporation or organization)</div>
            </td>
            <td style="width: 2%; vertical-align: bottom;">&#160;</td>
            <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(I.R.S. Employer Identification No.)</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z350d0fedd55f471cb6f808f022823f27" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">140 58th Street, Building A, Suite 2100</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Brooklyn, New York</div>
            </td>
            <td style="width: 2%; vertical-align: bottom;">&#160;</td>
            <td style="width: 49%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">11220</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(Address of Principal Executive Offices)</div>
            </td>
            <td style="width: 2%; vertical-align: bottom;">&#160;</td>
            <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(Zip Code)</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">Securities to be registered pursuant to Section 12(b) of the Act:</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zd6c809d61bb74737a304b41207a54d49" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td nowrap="nowrap" style="width: 49%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Title of each class</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">to be so registered</div>
            </td>
            <td style="width: 2%; vertical-align: bottom;">&#160;</td>
            <td nowrap="nowrap" style="width: 49%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Name of each exchange on which</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">each class is to be registered</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Common stock, par value $0.005 per share</div>
            </td>
            <td style="width: 2%; vertical-align: bottom;">&#160;</td>
            <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">The Nasdaq Stock Market LLC</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div>If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction
        A.(c) or (e), check the following box. &#9746;</div>
      <div><br>
      </div>
      <div>If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction
        A.(d) or (e), check the following box. &#9744;</div>
      <div><br>
      </div>
      <div>If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. &#9744;</div>
      <div><br>
      </div>
      <div>Securities Act registration statement file number to which this form relates: <font style="font-weight: bold;">Not
          applicable</font></div>
      <div><font style="font-weight: bold;"> <br>
        </font></div>
      <div>Securities to be registered pursuant to Section 12(g) of the Act: <font style="font-weight: bold;">None.</font></div>
      <div><font style="font-weight: bold;"> <br>
        </font></div>
      <div>
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><font style="font-weight: bold;"> </font></div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zd1faad0ca1724d97bf33be4bb7292b9f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 1.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;">Description of Registrant&#8217;s Securities to be Registered.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: justify;">The description of the common stock, par value $0.005 per share, of Brooklyn ImmunoTherapeutics, Inc. (the &#8220;Company&#8221;) as included under the caption
        &#8220;Description of Capital Stock&#8221; in the Prospectus forming a part of the Company&#8217;s Registration Statement on Form S-3, originally filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) on August 13, 2021 (File No. 333-258816) (the
        &#8220;Registration Statement&#8221;), is hereby incorporated by reference herein. In addition, the above-referenced description included in any Prospectus relating to the Registration Statement filed with the Commission pursuant to Rule 424(b) under the
        Securities Act of 1933, as amended, shall be deemed to be incorporated by reference herein.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="za819f0d10f04400ea54e5cb6a06d240e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 2.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;">Exhibits.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: justify;">In accordance with the &#8220;Instructions as to Exhibits&#8221; with respect to Form 8-A, no exhibits are required to be filed hereunder because no other securities of
        the Company are registered on the Nasdaq Global Market and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.</div>
      <div><br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">SIGNATURE</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div>Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the Company has duly caused this Registration Statement to be
        signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York on October 22, 2021.</div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="zaf99962265af4b71bdeecdf909444ec4" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="text-indent: -10pt; margin-left: 10pt;"><font style="color: rgb(0, 0, 0);">Date: October </font>22<font style="color: rgb(0, 0, 0);">, 2021</font></div>
            </td>
            <td style="vertical-align: bottom;" colspan="2">
              <div style="text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-weight: bold;">Brooklyn ImmunoTherapeutics, Inc.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="width: 5%; vertical-align: bottom;">
              <div style="text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0);">By:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="color: rgb(0, 0, 0);">/s/ Howard J. Federoff</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="width: 5%; vertical-align: bottom;">
              <div style="text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0);">Name:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom;">
              <div style="text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0);">Howard J. Federoff</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="width: 5%; vertical-align: bottom;">
              <div style="text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0);">Title:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom;">
              <div style="text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0);">Chief Executive Officer and President</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>


</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
